Gadong Taohy

CEFODIZIME SODIUM PDF

Cefodizime Sodium ≥96% (HPLC); CAS Number: ; Synonym: 5-Thia azabicyclo[]octenecarboxylic acid. Cefodizime Sodium is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cefodizime Sodium is available on the. The first dose of cefodizime in patients with impaired renal function is the . The sodium content of cefodizime (75 mg/g) should be taken into.

Author: Goshura Zulut
Country: Belgium
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 11 June 2015
Pages: 125
PDF File Size: 3.11 Mb
ePub File Size: 4.48 Mb
ISBN: 385-3-81813-968-1
Downloads: 37096
Price: Free* [*Free Regsitration Required]
Uploader: Doktilar

Tolterodine Cefotaxime may decrease the excretion rate of Tolterodine which could result in a higher serum level. Trimebutine Cefotaxime may decrease the excretion rate of Trimebutine which could result in a higher serum level.

Cefodizime Sodium –

Tolazamide Cefotaxime may decrease the excretion rate of Tolazamide which could result in a higher serum level. Paliperidone Cefotaxime may decrease the excretion rate of Paliperidone sodkum could result in a higher soeium level. Sulthiame The therapeutic efficacy of Sulthiame can be decreased when used in combination with Cefotaxime. Prednisone Cefotaxime may decrease the excretion rate of Prednisone which could result in a higher serum level.

Sulodexide The therapeutic efficacy of Sulodexide can be decreased when used in combination with Cefotaxime. Dimethyl sulfoxide Cefotaxime may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.

Quetiapine Cefotaxime may decrease the excretion rate of Quetiapine which could result in a higher serum level. The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins PBPs. Dexketoprofen Cefotaxime may decrease the excretion rate of Dexketoprofen which could result in a higher serum level.

Ceftaroline fosamil The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Ceftaroline fosamil. Difenpiramide The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Difenpiramide.

Potassium cefdizime Cefotaxime may decrease the excretion rate of Potassium sulfate which could result in a higher serum level. Magnesium carbonate Cefotaxime may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.

  ICH BIN EIN STERN INGE AUERBACHER PDF

Lithium hydroxide Cefotaxime may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level. Levocarnitine Cefotaxime may decrease the excretion rate of L-Carnitine which could result in a higher serum level.

Cefotaxime

Naloxone Cefotaxime may decrease the excretion rate of Naloxone which could result in a higher serum level. Magnesium chloride Cefotaxime may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.

Megestrol acetate Cefotaxime may decrease the excretion rate of Megestrol acetate which could result in a higher serum level. Cefodizije The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Pentamidine. Fexofenadine The excretion of Fexofenadine can be decreased when combined with Cefotaxime. Chromium gluconate Cefotaxime may decrease the excretion rate of Chromium gluconate which could result in a higher serum level. Corifollitropin alfa Cefotaxime may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.

Cefodizime

Colistimethate The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Colistimethate. Ancrod The therapeutic efficacy of Ancrod can be decreased when used in combination with Cefotaxime. In clinical trials, the most frequently used adult dosages ranged from 2 grams to 4 grams IM or IV cefodiziem day given as a single dose or in 2 divided doses. Tasimelteon Cefotaxime may decrease the excretion rate of Tasimelteon which could result in a higher serum level.

Ribostamycin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Ribostamycin. Clozapine Cefotaxime may decrease the excretion rate of Clozapine which could result in a higher serum level. Geneticin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Geneticin. Lithium cation Cefotaxime may decrease the excretion rate of Lithium cation which could result in a higher serum level.

Cefodizime The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefodizime. Imidafenacin Cefotaxime may decrease the excretion rate of Imidafenacin which could result in a higher serum level.

  7555CN DATASHEET PDF

Lofexidine Cefotaxime may decrease the excretion rate of Lofexidine which could result in a higher serum level. Naldemedine Cefotaxime may decrease the excretion rate of Naldemedine which could result in a higher serum level. Temozolomide Cefotaxime may decrease the excretion rate of Temozolomide which could result in a higher serum level.

Opium Cefotaxime may decrease the excretion rate of Opium which could result in a higher serum level. Bacillus calmette-guerin substrain tice live antigen The therapeutic efficacy of Bacillus calmette-guerin sodiuk tice live antigen can be decreased when used in combination with Cefotaxime.

Colchicine Cefotaxime may decrease the excretion rate of Colchicine which could result in a higher serum level. Isoxicam The risk or severity of nephrotoxicity can be increased when Sodiuk is combined with Isoxicam.

Cefovizime create an account? Cefradine Cefotaxime may decrease the excretion rate of Cefradine which could result in a higher serum level. Milrinone Cefotaxime may decrease the excretion rate of Milrinone which could cefodisime in a higher serum level.

Testolactone Cefotaxime may decrease the excretion rate of Testolactone which could result in a higher serum level. Cefotiam The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefotaxime. Tepoxalin The risk or severity of nephrotoxicity sodoum be increased when Cefotaxime is combined with Tepoxalin. Gadobenic acid Cefotaxime may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.

Methimazole Cefotaxime may decrease the excretion rate of Methimazole which could result in a higher serum level.

Felbamate The cefodozime efficacy of Felbamate can be decreased when used in combination with Cefotaxime. Nitrazepam The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Cefotaxime.